A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 40
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LTBI
Long Form : latent tuberculosis
No. Year Title Co-occurring Abbreviation
2021 3D host cell and pathogen-based bioassay development for testing anti-tuberculosis (TB) drug response and modeling immunodeficiency. BCG, EVR, HIV, Mtb, RIF, TB, TB
2021 Circulating IgA/IgG memory B cells against Mycobacterium tuberculosis dormancy-associated antigens Rv2659c and Rv3128c in active and latent tuberculosis. MBCs, TB
2021 Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis. ---
2021 Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals. non-TNFi, PT, TB, TNFi
2021 Latent infection screening and prevalence in cancer patients born outside of Australia: a universal versus risk-based approach? HIV
2021 Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test. IBD, TNF-alpha
2021 Resistance to TST/IGRA conversion in Uganda: Heritability and Genome-Wide Association Study. REML, RSTRs, TB
2021 Role of resuscitation promoting factors in reactivation of latent tuberculosis during high glucose conditions employing human granuloma in vitro model. PBMCs, TB
2021 [Frequency Distribution and Risk Factors for Latent Tuberculosis in Contact Persons: Cologne 2012-2016]. IGRA
10  2020 Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index-Latent Tuberculosis Co-morbidity. AMPs, BMI, hBD-2, HNP1-3, LBMI, NBMI, TB
11  2020 Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review. IP, TB
12  2020 High yield from repeated testing for tuberculosis among high-risk citizens in Denmark. IGRA
13  2020 Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis. AEs, aRR, TB, US
14  2020 Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants. ---
15  2020 Latent tuberculosis in pregnant women: a patient perspective. TB
16  2020 Prevalence of tuberculosis in migrant children in Switzerland and relevance of current screening guidelines. aOR, CI, IQR, TB, TBD, TST
17  2020 Programmatic Effectiveness of Latent Tuberculosis Care Cascade in a Community Health Center. BMS, CHC, TB
18  2020 Usefulness of the IgA and IgG Responses to Macrophage Migration Inhibitory Factor for the Diagnosis of Tuberculosis. ATB, Ig, MIF, NI, QFT-GIT, TB
19  2019 Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. HBV, HCV
20  2019 Latent Tuberculosis in a Paediatric Health Worker: A Case Report. TB
21  2018 The Microbiome and Tuberculosis: Early Evidence for Cross Talk. TB
22  2017 High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection. aRR, CI, RR, TB
23  2017 Modulation of Mycobacterium tuberculosis-specific humoral immune responses is associated with Strongyloides stercoralis co-infection. Mtb, Ss, Ss
24  2017 Optimizing the management of children with latent tuberculosis infection. ---
25  2017 Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis. MDR, TB
26  2016 B cell responses in older adults with latent tuberculosis: Considerations for vaccine development. Mtb, TLR, TST
27  2016 Immunological Roles of Elevated Plasma Levels of Matricellular Proteins in Japanese Patients with Pulmonary Tuberculosis. ELISA, ELISPOTs, Gal-9, HCs, MCPs, Mtb, OPN, sCD44, TB
28  2015 Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia. ART, IDU
29  2015 Hepatotoxicity from antituberculous therapy in the elderly: a systematic review. TB
30  2015 Interferon Gamma-Based Detection of Latent Tuberculosis Infection in the Border States of Nuevo Leon and Tamaulipas, Mexico. QFT-GIT, TB, TST
31  2014 Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study. QFT-GIT, TNF, TST, TST/QFT
32  2014 The intensity of QuantiFERON TB-gold response does not differentiate active from latent tuberculosis. QFT
33  2012 Education-service partnership to promote best practices in a latent tuberculosis infection program. ---
34  2012 T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia. PTB
35  2011 An evaluation of factors associated with taking and responding positive to the tuberculin skin test in individuals with HIV/AIDS. CI, TST
36  2011 Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. TB
37  2010 Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia. IGRAs, QFT-GIT, TST
38  2009 Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. BCG, IGRA, OR, TB, TST
39  2009 QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study. IFN-gamma, QFT-G, RA, TST
40  2009 Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test. HCWs, QFT-G, TST